academic article

• Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial..  The Lancet. Oncology.  17:1558-1568. 2016
• A Case of Primary Mammary Analog Secretory Carcinoma (MASC) of the Thyroid Masquerading as Papillary Thyroid Carcinoma: Potentially More than a One Off..  Head and neck pathology.  10:405-413. 2016
• Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma. 2015
• Ubiquitin-specific peptidase 20 regulates Rad17 stability, checkpoint kinase 1 phosphorylation and DNA repair by homologous recombination. 2014
• The role of the human psoralen 4 (hPso4) protein complex in replication stress and homologous recombination. 2014
• A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers..  Translational oncology.  :-. 2014
• A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcoma..  Cancers.  5:418-429. 2013
• Cytotoxic activity of the titanium alkoxide (OPy)(2)Ti(4AP)(2) against cancer colony forming cells..  Investigational new drugs.  30:114-120. 2012
• Targeting the Transposase Domain of the DNA Repair Component Metnase to Enhance Chemotherapy..  Cancer research.  72:6200-6208. 2012
• Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining..  Proceedings of the National Academy of Sciences of the United States of America.  108:540-545.
• Metnase/SETMAR: a domesticated primate transposase that enhances DNA repair, replication, and decatenation..  Genetica.  138:559-566.
• Synthetic lethality: exploiting the addiction of cancer to DNA repair..  Blood.  117:6074-6082.
• The Role of PCNA Posttranslational Modifications in Translesion Synthesis..  Journal of nucleic acids.  2010:-.